3.6
—
3.6
—
The Transtubular Potassium Gradient (TTKG) Calculator estimates the potassium concentration gradient across the cortical collecting duct, providing insight into aldosterone-mediated potassium secretion. The TTKG helps determine whether the kidney is appropriately handling potassium in the setting of hypo- or hyperkalemia, distinguishing renal from extrarenal causes of potassium disorders. It is particularly useful in evaluating hyperkalemia to assess whether aldosterone-driven renal potassium secretion is intact.
The TTKG is calculated as: TTKG = (Urine K / Serum K) / (Urine Osm / Serum Osm). This formula adjusts the urine-to-serum potassium ratio for the degree of water reabsorption in the medullary collecting duct. Because the cortical collecting duct (where aldosterone-mediated potassium secretion occurs) is upstream of the medullary collecting duct (where water is concentrated), the TTKG back-calculates the potassium concentration at the cortical collecting duct level by adjusting for water reabsorption using the osmolality ratio.
For the TTKG to be valid, two conditions must be met: urine osmolality must be greater than serum osmolality (indicating that ADH is active and the urine has been concentrated), and urine sodium must be at least 25 mEq/L (ensuring adequate distal sodium delivery for potassium secretion). If these prerequisites are not met, the TTKG cannot be reliably interpreted.
In hyperkalemia (serum K above 5.5), a TTKG below 7 suggests impaired renal potassium excretion. This is seen in hypoaldosteronism (Type 4 RTA, adrenal insufficiency, ACE inhibitor/ARB use, NSAID use) and conditions that impair the collecting duct's response to aldosterone (potassium-sparing diuretics, calcineurin inhibitors). A TTKG above 7 in hyperkalemia suggests appropriate renal potassium secretion, pointing to extrarenal causes such as massive tissue breakdown (rhabdomyolysis, tumor lysis), transcellular shift (acidosis, insulin deficiency), or excessive potassium intake.
In hypokalemia (serum K below 3.5), a TTKG above 3 suggests renal potassium wasting. Causes include primary or secondary hyperaldosteronism, diuretic use, Bartter and Gitelman syndromes, renal tubular acidosis (Types 1 and 2), and magnesium depletion. A TTKG below 3 in hypokalemia suggests appropriate renal potassium conservation, pointing to extrarenal losses (diarrhea, vomiting, laxative abuse) or transcellular shift (alkalosis, insulin, beta-agonists).
While the TTKG has been a valuable clinical tool, recent physiological studies have questioned some of its underlying assumptions, particularly regarding the impermeability of the cortical collecting duct to water and the behavior of urea in the medullary collecting duct. Some experts now recommend direct urinary potassium measurement and potassium-to-creatinine ratio as alternatives. Despite these debates, the TTKG remains widely taught and used as part of the systematic evaluation of potassium disorders, and its clinical utility has been validated in numerous clinical studies.
TTKG = (Urine K / Serum K) / (Urine Osm / Serum Osm). This formula estimates the potassium concentration gradient at the cortical collecting duct by correcting the urine potassium for medullary water reabsorption (using the osmolality ratio). Prerequisites: urine osmolality must exceed serum osmolality, and urine sodium should be at least 25 mEq/L.
In hyperkalemia: TTKG below 7 suggests impaired renal K excretion (hypoaldosteronism); above 7 suggests extrarenal cause. In hypokalemia: TTKG above 3 suggests renal K wasting; below 3 suggests appropriate renal conservation (GI loss or shift). Normal TTKG is 4-8 on a regular diet.
Inputs
Results
TTKG of 1.9 with hyperkalemia indicates the kidney is not adequately secreting potassium. Check aldosterone, renin, and consider medication causes.
Inputs
Results
TTKG of 5.8 with hypokalemia indicates inappropriate renal potassium excretion. Consider diuretic use, hyperaldosteronism, or Gitelman syndrome.
The TTKG estimates the potassium concentration gradient between the cortical collecting duct lumen and the peritubular blood. It reflects the net effect of aldosterone on potassium secretion. Higher values indicate more potassium secretion (aldosterone effect), while lower values indicate less secretion.
Urine osmolality must exceed serum osmolality (confirming ADH activity and water reabsorption in the medullary collecting duct). Urine sodium should be at least 25 mEq/L (ensuring adequate distal sodium delivery for potassium secretion). If either condition is unmet, the TTKG is unreliable.
On a normal diet, TTKG is approximately 4-8. After potassium loading, it should increase above 10 (demonstrating aldosterone-mediated secretion). During potassium restriction, it decreases below 3 (appropriate conservation). These ranges assume normal aldosterone function.
Aldosterone stimulates potassium secretion by the principal cells of the cortical collecting duct by upregulating ENaC (sodium reabsorption) and ROMK (potassium secretion) channels. This increases the TTKG. Aldosterone deficiency or resistance reduces TTKG, impairing potassium excretion.
Yes. Aldosterone antagonists (spironolactone, eplerenone) lower TTKG. ACE inhibitors and ARBs reduce aldosterone production, lowering TTKG. Trimethoprim blocks ENaC, reducing potassium secretion. Fludrocortisone (synthetic mineralocorticoid) increases TTKG. These drug effects should be considered in interpretation.
The TTKG has been questioned on theoretical grounds (assumptions about cortical collecting duct water permeability may not always hold). However, it remains widely used in clinical practice and education. Alternative approaches include spot urine K/creatinine ratio and 24-hour urine potassium excretion.
Spot urine potassium concentration is affected by urine volume and concentration. The TTKG corrects for water reabsorption, providing a better estimate of tubular potassium secretory activity. A concentrated urine may have high urine K simply from water reabsorption, not increased secretion — TTKG accounts for this.
Type 4 RTA results from aldosterone deficiency (Addison's disease, diabetic nephropathy, chronic interstitial nephritis) or resistance (pseudohypoaldosteronism, potassium-sparing diuretics, calcineurin inhibitors). It presents with hyperkalemia, mild metabolic acidosis, and low TTKG despite hyperkalemia.
Check aldosterone and renin when TTKG is inappropriately low in hyperkalemia (below 7). Low aldosterone with high renin suggests adrenal insufficiency. Low aldosterone with low renin suggests hyporeninemic hypoaldosteronism (common in diabetic nephropathy). Normal/high aldosterone with low TTKG suggests aldosterone resistance.
The TTKG is less reliable in AKI because tubular function is globally impaired. Urine osmolality may not exceed serum osmolality (ADH-independent urine), and sodium delivery to the distal nephron may be abnormal. In AKI, clinical context and serial potassium monitoring are more important than the TTKG.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
Kt/V Calculator (Dialysis Adequacy)
Dialysis & Electrolyte Calculators
Delta Ratio (Delta Gap) Calculator
Dialysis & Electrolyte Calculators
Serum Osmolality Calculator
Dialysis & Electrolyte Calculators
Urine Anion Gap Calculator
Dialysis & Electrolyte Calculators
Corrected Calcium Calculator
Dialysis & Electrolyte Calculators
Corrected Magnesium Calculator
Dialysis & Electrolyte Calculators
